Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
XCHG Limited - ADS | XCH | Mar 31, 2025 | 1.20 | -4.76 |
Xencor | XNCR | Mar 31, 2025 | 10.64 | -5.25 |
Xenetic Biosciences | XBIO | Mar 31, 2025 | 2.61 | -16.35 |
Xenia Hotels & Resorts | XHR | Mar 31, 2025 | 11.76 | -0.42 |
Xenon Pharmaceuticals | XENE | Mar 31, 2025 | 33.55 | -2.07 |
Xeris Biopharma | XERS | Mar 31, 2025 | 5.49 | -1.61 |
Xerox | XRX | Mar 31, 2025 | 4.83 | -5.85 |
XIAO-I ADR | AIXI | Mar 31, 2025 | 4.29 | +10.00 |
Xilio Therapeutics | XLO | Mar 31, 2025 | 0.72 | -2.90 |
Xinyuan Real Estate ADR | XIN | Mar 31, 2025 | 2.57 | -1.53 |
XOMA | XOMA | Mar 31, 2025 | 19.93 | -1.97 |
XOMA A Pref | XOMAP | Mar 31, 2025 | 25.84 | +0.23 |
XOMA B Pref | XOMAO | Mar 31, 2025 | 25.39 | -0.15 |
Xometry A | XMTR | Mar 31, 2025 | 24.92 | -3.75 |
XORTX Therapeutics | XRTX | Mar 31, 2025 | 0.96 | -1.03 |
Xos | XOS | Mar 31, 2025 | 3.01 | -12.50 |
XP A | XP | Mar 31, 2025 | 13.75 | -7.09 |
XPEL | XPEL | Mar 31, 2025 | 29.38 | -4.86 |
XPeng A ADR | XPEV | Mar 31, 2025 | 20.72 | +5.18 |
Xperi | XPER | Mar 31, 2025 | 7.72 | -1.53 |
XPLR Infrastructure, LP | XIFR | Mar 31, 2025 | 9.50 | 0.00 |
XPO Logistics | XPO | Mar 31, 2025 | 107.58 | +0.46 |
Xponential Fitness A | XPOF | Mar 31, 2025 | 8.33 | +8.04 |
Xtant Medical | XTNT | Mar 31, 2025 | 0.47 | -3.96 |
XTI Aerospace | XTIA | Mar 31, 2025 | 1.09 | -11.38 |
XTL Biopharmaceuticals ADR | XTLB | Mar 31, 2025 | 1.20 | -5.91 |
Xunlei ADR | XNET | Mar 31, 2025 | 4.49 | +0.90 |
XWELL | XWEL | Mar 31, 2025 | 1.02 | -2.86 |
Xylem | XYL | Mar 31, 2025 | 119.46 | +0.02 |
Xylo Technologies ADR | XYLO | Mar 31, 2025 | 4.91 | -0.81 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.